Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.60
-0.05 (-3.03%)
At close: Jun 27, 2025, 3:59 PM
1.62
0.93%
After-hours: Jun 27, 2025, 05:50 PM EDT
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
15
Market Cap
119.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|